Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype?

BS Andresen, P Bross, S Udvari, J Kirk, G Gray, S Kmoch, N Chamoles, I Knudsen, V Winter, B Wilcken, I Yokota, K Hart, S Packman, JP Harpey, JM Saudubray, DE Hale, L Bolund, S Kolvraa, N Gregersen

. 1997 ; 6 (5) : 695-707.

Jazyk angličtina Země Anglie, Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc14043432

Grantová podpora
IZ3204 MZ0 CEP - Centrální evidence projektů

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most commonly recognized defect of mitochondrial beta-oxidation. It is potentially fatal, but shows a wide clinical spectrum. The aim of the present study was to investigate whether any correlation exists between MCAD genotype and disease phenotype. We determined the prevalence of the 14 known and seven previously unknown non-G985 mutations in 52 families with MCAD deficiency not caused by homozygosity for the prevalent G985 mutation. This showed that none of the non-G985 mutations are prevalent, and led to the identification of both disease-causing mutations in 14 families in whom both mutations had not previously been reported. We then evaluated the severity of the mutations identified in these 14 families. Using expression of mutant MCAD in Escherichia coli with or without co-overexpression of the molecular chaperonins GroESL we showed that five of the missense mutations affect the folding and/or stability of the protein, and that the residual enzyme activity of some of them could be modulated to a different extent depending on the amounts of available chaperonins. Thus, some of the missense mutations may result in relatively high levels of residual enzyme activity, whereas the mutations leading to premature stop codons will result in no residual enzyme activity. By correlating the observed types of mutations identified to the clinical/biochemical data in the 14 patients in whom we identified both disease-causing mutations, we show that a genotype/phenotype correlation in MCAD deficiency is not straightforward. Different mutations may contribute with different susceptibilities for disease precipitation, when the patient is subjected to metabolic stress, but other genetic and environmental factors may play an equally important role.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14043432
003      
CZ-PrNML
005      
20140313155208.0
007      
ta
008      
140124s1997 enk f 000 0|eng||
009      
AR
035    __
$a (PubMed)9158144
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a enk
100    1_
$a Andresen, B. S. $u Center for Medical Molecular Biology, Aarhus University Hospital and Faculty of Health Science, Denmark. brage@biobase.dk $7 gn_A_00006548
245    14
$a The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? / $c BS Andresen, P Bross, S Udvari, J Kirk, G Gray, S Kmoch, N Chamoles, I Knudsen, V Winter, B Wilcken, I Yokota, K Hart, S Packman, JP Harpey, JM Saudubray, DE Hale, L Bolund, S Kolvraa, N Gregersen
504    __
$a Literatura
520    9_
$a Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most commonly recognized defect of mitochondrial beta-oxidation. It is potentially fatal, but shows a wide clinical spectrum. The aim of the present study was to investigate whether any correlation exists between MCAD genotype and disease phenotype. We determined the prevalence of the 14 known and seven previously unknown non-G985 mutations in 52 families with MCAD deficiency not caused by homozygosity for the prevalent G985 mutation. This showed that none of the non-G985 mutations are prevalent, and led to the identification of both disease-causing mutations in 14 families in whom both mutations had not previously been reported. We then evaluated the severity of the mutations identified in these 14 families. Using expression of mutant MCAD in Escherichia coli with or without co-overexpression of the molecular chaperonins GroESL we showed that five of the missense mutations affect the folding and/or stability of the protein, and that the residual enzyme activity of some of them could be modulated to a different extent depending on the amounts of available chaperonins. Thus, some of the missense mutations may result in relatively high levels of residual enzyme activity, whereas the mutations leading to premature stop codons will result in no residual enzyme activity. By correlating the observed types of mutations identified to the clinical/biochemical data in the 14 patients in whom we identified both disease-causing mutations, we show that a genotype/phenotype correlation in MCAD deficiency is not straightforward. Different mutations may contribute with different susceptibilities for disease precipitation, when the patient is subjected to metabolic stress, but other genetic and environmental factors may play an equally important role.
590    __
$a bohemika - dle Pubmed
650    02
$a acyl-CoA-dehydrogenasa $7 D042964
650    12
$a acyl-CoA-dehydrogenasy $x genetika $x metabolismus $x nedostatek $7 D044944
650    02
$a mladiství $7 D000293
650    02
$a alely $7 D000483
650    02
$a western blotting $7 D015153
650    02
$a chaperonin 10 $x genetika $x metabolismus $7 D018835
650    02
$a chaperon hsp60 $x genetika $x metabolismus $7 D018834
650    02
$a dítě $7 D002648
650    02
$a předškolní dítě $7 D002675
650    02
$a aktivace enzymů $7 D004789
650    02
$a Escherichia coli $x genetika $7 D004926
650    02
$a exony $7 D005091
650    02
$a ženské pohlaví $7 D005260
650    12
$a heterozygot $7 D006579
650    02
$a lidé $7 D006801
650    02
$a kojenec $7 D007223
650    02
$a novorozenec $7 D007231
650    02
$a mužské pohlaví $7 D008297
650    12
$a mutace $7 D009154
650    02
$a rodokmen $7 D010375
650    02
$a fenotyp $7 D010641
650    02
$a polymerázová řetězová reakce $7 D016133
650    02
$a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
650    02
$a restrikční mapování $7 D015183
650    02
$a sekvenční analýza DNA $7 D017422
650    02
$a sekvenční delece $7 D017384
650    02
$a teplota $7 D013696
700    1_
$a Bross, P.
700    1_
$a Udvari, S.
700    1_
$a Kirk, J.
700    1_
$a Gray, G.
700    1_
$a Kmoch, Stanislav, $d 1963- $7 xx0056529 $u Institute for Inherited Metabolic Diseases, General Faculty Hospital and Charles University 1st School of Medicine, Prague, Czech Republic
700    1_
$a Chamoles, N.
700    1_
$a Knudsen, I.
700    1_
$a Winter, V.
700    1_
$a Wilcken, B.
700    1_
$a Yokota, I.
700    1_
$a Hart, K.
700    1_
$a Packman, S.
700    1_
$a Harpey, J. P.
700    1_
$a Saudubray, J. M.
700    1_
$a Hale, D. E.
700    1_
$a Bolund, L.
700    1_
$a Kolvraa, S.
700    1_
$a Gregersen, N.
773    0_
$t Human Molecular Genetics $x 0964-6906 $g Roč. 6, č. 5 (1997), s. 695-707 $p Hum Mol Genet $w MED00002077
773    0_
$p Hum Mol Genet $g 6(5):695-707, 1997 May $x 0964-6906
910    __
$a ABA008 $b B 1813 $y z $z 0
990    __
$a 20140124123326 $b ABA008
991    __
$a 20140313155217 $b ABA008
999    __
$a ok $b bmc $g 1008121 $s 841957
BAS    __
$a 3
BMC    __
$a 1997 $b 6 $c 5 $d 695-707 $i 0964-6906 $m Human molecular genetics $x MED00002077
GRA    __
$a IZ3204 $p MZ0
LZP    __
$a 2013-01/ewbo

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...